Samsara BioCapital »

Science 37 Holdings shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Science 37 Holdings shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Science 37 Holdings

Tip: Access up to 7 years of quarterly data

All positions including Science 37 Holdings held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Science 37 Holdings by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2023-12-31 $240k 45k 5.34

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Rayzebio
Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Neurogene (NGNE)
Graphite Bio
Nkarta (NKTX)
Acelyrin (SLRN)
Zymeworks Del (ZYME)
Lyra Therapeutics (LYRA)
Syros Pharmaceuticals Com New (SYRS)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Hillevax (HLVX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Science 37 Holdings

Redmile Group
Kent Lake Capital
Russell Investments
Vanguard Group
MIC Capital Management UK
Alyeska Investment Group
Citadel Advisors
Samsara BioCapital
Robeco Investment Management
UBS Group
M&r Capital Management
Jpmorgan Chase & Co
Bank of America Corporation
Wells Fargo & Company
Citigroup

View all funds holding Science 37 Holdings